Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -58.28% is 13% below its 5-year average of -51.35%, near the high end of its 5-year range (-212.45%–-21.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.11% below its 12-month average of -52.93%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -58.28%.
RETURN ON INVESTED CAPITAL (ROIC)
-58.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-52.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-53.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-51.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-37.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-26.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-19.17%
CURRENT VS TTM AVG
-10.11%
CURRENT VS 3Y AVG
-8.62%
CURRENT VS 5Y AVG
-13.50%
CURRENT VS 10Y AVG
-56.41%
CURRENT VS 15Y AVG
-122.61%
CURRENT VS 20Y AVG
-203.96%
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-63.43%
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Return on Invested Capital (ROIC)
-58.28%
TTM Avg
-52.93%
3Y Avg
-53.65%
5Y Avg
-51.35%
Market Cap
$2.77B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$2.99B
Return on Invested Capital (ROIC)
9.95%
TTM Avg
-25.98%
3Y Avg
-51.77%
5Y Avg
-51.95%
Market Cap
$2.73B
Return on Invested Capital (ROIC)
2.04%
TTM Avg
-4.01%
3Y Avg
-5.25%
5Y Avg
-2.96%
Market Cap
$3.03B
Return on Invested Capital (ROIC)
-13.88%
TTM Avg
-29.89%
3Y Avg
-36.62%
5Y Avg
-30.08%
Market Cap
$2.71B
Return on Invested Capital (ROIC)
-28.60%
TTM Avg
-26.51%
3Y Avg
-39.35%
5Y Avg
-39.35%
Market Cap
$2.70B
Return on Invested Capital (ROIC)
6.69%
TTM Avg
7.54%
3Y Avg
8.48%
5Y Avg
6.84%
Market Cap
$3.06B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-45.69%
3Y Avg
-35.19%
5Y Avg
-27.59%
Market Cap
$2.69B
Return on Invested Capital (ROIC)
-28.02%
TTM Avg
-99.23%
3Y Avg
-79.58%
5Y Avg
-63.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | -58.28% | -52.93% | -53.65% | -51.35% |
| TransMedics Group, Inc. (TMDX)vs › | $2.77B | 5.87% | 7.96% | -0.22% | -9.17% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $2.99B | 9.95% | -25.98% | -51.77% | -51.95% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 2.04% | -4.01% | -5.25% | -2.96% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.03B | -13.88% | -29.89% | -36.62% | -30.08% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | -28.60% | -26.51% | -39.35% | -39.35% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | 6.69% | 7.54% | 8.48% | 6.84% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.06B | -50.82% | -45.69% | -35.19% | -27.59% |
| Precigen, Inc. (PGEN)vs › | $2.69B | -28.02% | -99.23% | -79.58% | -63.04% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 15.45% | 14.86% | 6.92% | -8.67% |
ROIC
-58.3%
ROE
-74.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -58.28% |
| 2026-03-31 | -45.57% |
| 2025-12-31 | -41.02% |
| 2025-09-30 | -55.64% |
| 2025-06-30 | -64.13% |
| 2025-03-31 | -57.79% |
| 2024-12-31 | -52.99% |
| 2024-09-30 | -43.34% |
| 2024-06-30 | -34.05% |
| 2024-03-31 | -53.18% |
| 2023-12-31 | -212.45% |
| 2023-09-30 | -122.25% |
| 2023-06-30 | -84.18% |
| 2023-03-31 | -67.64% |
| 2022-12-31 | -61.44% |
| 2022-09-30 | -66.14% |
| 2022-06-30 | -58.29% |
| 2022-03-31 | -44.08% |
| 2021-12-31 | -37.80% |
| 2021-09-30 | -28.56% |
| 2021-06-30 | -21.52% |
| 2021-03-31 | -15.88% |
| 2020-12-31 | -17.13% |
| 2020-09-30 | -9.43% |
| 2020-06-30 | -17.97% |
| 2019-12-31 | -98.20% |
| 2017-12-31 | -4.05% |
| 2017-09-30 | 0.56% |
| 2017-06-30 | -0.94% |
| 2017-03-31 | -5.56% |
| 2016-12-31 | -3.97% |
| 2016-09-30 | -4.37% |
| 2016-06-30 | -2.49% |
| 2016-03-31 | 2.27% |
| 2015-12-31 | 0.95% |
| 2015-09-30 | 1.31% |
| 2015-06-30 | 0.55% |
| 2015-03-31 | -1.04% |
| 2014-12-31 | -1.00% |
| 2014-09-30 | -5.48% |
| 2014-06-30 | -5.61% |
| 2014-03-31 | -4.43% |
| 2013-12-31 | -6.94% |
| 2013-09-30 | 13.82% |
| 2013-06-30 | 40.20% |
| 2013-03-31 | 10.84% |
| 2012-12-31 | 16.93% |
| 2012-09-30 | -29.73% |
| 2012-06-30 | -2681.05% |
| 2012-03-31 | -42.24% |
| 2011-12-31 | -41.41% |
| 2011-09-30 | -3.71% |
| 2011-06-30 | -3.13% |
| 2011-03-31 | -0.71% |
| 2010-12-31 | 3.72% |
| 2010-09-30 | 2.98% |
| 2010-06-30 | 3.15% |
| 2010-03-31 | -7.37% |
| 2009-12-31 | -8.41% |
| 2009-09-30 | -4.44% |
| 2009-06-30 | 2.46% |
| 2009-03-31 | 4.70% |
| 2008-12-31 | 3.10% |
| 2008-09-30 | 4.15% |
| 2008-06-30 | -1.44% |
| 2008-03-31 | 3.09% |
